MMAA
Basic information
Region (hg38): 4:145599042-145660033
Links
Phenotypes
GenCC
Source:
- methylmalonic aciduria, cblA type (Definitive), mode of inheritance: AR
- methylmalonic aciduria, cblA type (Definitive), mode of inheritance: AR
- methylmalonic aciduria, cblA type (Definitive), mode of inheritance: AR
- methylmalonic aciduria, cblA type (Strong), mode of inheritance: AR
- methylmalonic aciduria, cblA type (Supportive), mode of inheritance: AR
- methylmalonic aciduria, cblA type (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Methylmalonic acidemia, cblA type | AR | Biochemical | Long-term dietary (high-calorie diet low in propiogenic amino acid precursors with carnitine supplementation) and medical management (eg, IM hydroxocobalamin, antibiotics to decrease propionate production) is indicated; Fasting and high-protein consumption should be avoided; In the emergent setting, prompt recognition and appropriate metabolic care may be beneficial to decrease morbidity and mortality; Antioxidants for optic nerve atrophy may be beneficial; Liver/kidney transplant has been described in methylmalonic acidemia | Biochemical; Hematologic; Neurologic; Ophthalmologic | 6132336; 12438653; 20301409; 21545677; 23026888; 34652574 |
ClinVar
This is a list of variants' phenotypes submitted to
- Methylmalonic aciduria, cblA type (57 variants)
- not provided (9 variants)
- Methylmalonic acidemia (8 variants)
- Methylmalonic aciduria of the cblA complementation type (1 variants)
- MMAA-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MMAA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 132 | 134 | ||||
missense | 79 | 96 | ||||
nonsense | 22 | 18 | 41 | |||
start loss | 1 | |||||
frameshift | 27 | 22 | 50 | |||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 12 | |||||
splice region | 1 | 3 | 17 | 21 | ||
non coding | 83 | 47 | 28 | 158 | ||
Total | 58 | 60 | 167 | 180 | 31 |
Highest pathogenic variant AF is 0.0000263
Variants in MMAA
This is a list of pathogenic ClinVar variants found in the MMAA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-145619402-G-C | not specified • Methylmalonic aciduria, cblA type | Conflicting classifications of pathogenicity (Jan 12, 2018) | ||
4-145619404-G-T | Methylmalonic aciduria, cblA type | Uncertain significance (Jan 13, 2018) | ||
4-145619405-C-A | Methylmalonic aciduria, cblA type | Uncertain significance (Jan 13, 2018) | ||
4-145619405-C-T | Methylmalonic aciduria, cblA type | Uncertain significance (Jan 12, 2018) | ||
4-145619417-G-C | Methylmalonic aciduria, cblA type | Uncertain significance (Jan 13, 2018) | ||
4-145619443-G-C | Likely benign (May 24, 2021) | |||
4-145619459-C-T | Benign (Jun 23, 2018) | |||
4-145627322-G-A | Uncertain significance (Sep 23, 2022) | |||
4-145638826-A-C | Benign (Aug 07, 2018) | |||
4-145639084-A-G | not specified • Methylmalonic aciduria, cblA type | Benign (Jun 15, 2021) | ||
4-145639105-A-T | not specified | Benign (May 22, 2017) | ||
4-145639126-C-T | Methylmalonic aciduria, cblA type | Conflicting classifications of pathogenicity (Feb 26, 2021) | ||
4-145639136-G-A | Methylmalonic aciduria, cblA type • MMAA-related disorder | Conflicting classifications of pathogenicity (Apr 07, 2022) | ||
4-145639140-A-G | Methylmalonic aciduria, cblA type | Likely pathogenic (May 04, 2017) | ||
4-145639145-C-T | Methylmalonic aciduria, cblA type | Likely benign (Feb 22, 2023) | ||
4-145639146-A-G | Methylmalonic aciduria, cblA type • Inborn genetic diseases | Uncertain significance (May 02, 2024) | ||
4-145639153-TAC-T | Methylmalonic aciduria, cblA type | Likely pathogenic (Mar 06, 2018) | ||
4-145639154-A-G | Methylmalonic aciduria, cblA type | Likely benign (Jun 26, 2022) | ||
4-145639160-T-C | Methylmalonic aciduria, cblA type | Likely benign (Mar 24, 2022) | ||
4-145639172-T-C | Methylmalonic aciduria, cblA type | Likely benign (May 15, 2023) | ||
4-145639175-C-T | Methylmalonic aciduria, cblA type | Likely benign (Jun 05, 2019) | ||
4-145639178-A-C | Methylmalonic aciduria, cblA type | Likely benign (Sep 07, 2021) | ||
4-145639185-C-A | Methylmalonic aciduria, cblA type | Uncertain significance (Dec 14, 2021) | ||
4-145639189-T-A | Methylmalonic aciduria, cblA type | Likely pathogenic (May 31, 2023) | ||
4-145639192-GA-G | Methylmalonic aciduria, cblA type | Pathogenic (Jun 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MMAA | protein_coding | protein_coding | ENST00000281317 | 6 | 41773 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.40e-13 | 0.0774 | 125633 | 0 | 114 | 125747 | 0.000453 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.331 | 209 | 223 | 0.938 | 0.0000116 | 2685 |
Missense in Polyphen | 58 | 75.362 | 0.76962 | 881 | ||
Synonymous | 0.132 | 80 | 81.5 | 0.981 | 0.00000412 | 845 |
Loss of Function | 0.494 | 20 | 22.5 | 0.888 | 0.00000145 | 244 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000265 | 0.000265 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000715 | 0.000712 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000431 | 0.000425 |
Other | 0.000656 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: GTPase, binds and hydrolyzes GTP (PubMed:28497574, PubMed:20876572). Involved in intracellular vitamin B12 metabolism, mediates the transport of cobalamin (Cbl) into mitochondria for the final steps of adenosylcobalamin (AdoCbl) synthesis. Functions as a G-protein chaperone that assists AdoCbl cofactor delivery from MMAB to the methylmalonyl-CoA mutase (MUT) and reactivation of the enzyme during catalysis (PubMed:28497574, PubMed:20876572). {ECO:0000269|PubMed:20876572, ECO:0000269|PubMed:28497574}.;
- Pathway
- Metabolism of lipids;Propionyl-CoA catabolism;Mitochondrial Fatty Acid Beta-Oxidation;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism;Fatty acid metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
(Consensus)
Recessive Scores
- pRec
- 0.0990
Intolerance Scores
- loftool
- 0.293
- rvis_EVS
- -0.69
- rvis_percentile_EVS
- 15.12
Haploinsufficiency Scores
- pHI
- 0.108
- hipred
- N
- hipred_score
- 0.414
- ghis
- 0.572
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.164
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mmaa
- Phenotype
Gene ontology
- Biological process
- cobalamin metabolic process;cobalamin biosynthetic process
- Cellular component
- mitochondrial matrix
- Molecular function
- GTPase activity;protein binding;GTP binding;identical protein binding;protein homodimerization activity